Packed waiting rooms tell the story faster than any dashboard. Clinics across San Francisco report simultaneous spikes in influenza, SARS‑CoV‑2 and RSV, a stack of respiratory threats that once would have hit in sequence, not all at once.

The uncomfortable truth is that science did not suddenly fail; public health messaging did. As recommendations shifted on boosters, intervals and target groups, many residents simply checked out, even as neutralizing antibody titers and mucosal immunity quietly ebbed in the background.

Blame does not fall only on changing guidance, but it starts there. Confused by altered schedules and brand switches, people skipped updated mRNA doses and new RSV formulations, leaving a patchwork of protection in neighborhoods where viral load is now high and household attack rates are climbing.

What looks like bad luck is really system design. Mask mandates vanished, indoor ventilation upgrades stalled, and community testing shrank, while viral evolution and antigenic drift kept moving, exploiting every gap that fractured communication and fading vaccines left behind.